HomeEverythingEducation
Equities & FundsCrypto & Digital AssetsAI & TechnologyBusiness & CorporateUS Politics & PolicyGeopolitics & Global RiskMacro, Rates & FXCommodities & EnergyEuropean Politics & MarketsAsia-PacificReal Estate & Property
Story archiveAll categories
← All Stories

Neurocrine Biosciences CSO Jude Onyia sells $1.76m in stock

Created at 2 Jun · 10:26 PM2 sources2 events
IN SHORT

Neurocrine Biosciences Chief Scientific Officer Jude Onyia sold $1.76 million in company stock. The transaction involved shares of the pharmaceutical company.

✉Newsletter

PiQ Daily

Pick your topics. Get only what matters, on your cadence.

Key Numbers

$1.76mstock sale amount by CSO

Who's Involved

Jude Onyia
Chief Scientific Officer of Neurocrine Biosciences

↳ Why This Matters

Insider selling by a high-ranking executive can sometimes signal a lack of confidence in the company's future prospects, potentially impacting investor sentiment.

Key facts

  • Neurocrine Biosciences Chief Scientific Officer Jude Onyia sold $1.76 million in company stock.

Neurocrine Biosciences Chief Scientific Officer Jude Onyia sold $1.76 million in company stock. The transaction involved shares of the pharmaceutical company.

Frequently asked questions

Chief Scientific Officer Jude Onyia sold stock in Neurocrine Biosciences.

Jude Onyia sold $1.76 million worth of Neurocrine Biosciences stock.

Neurocrine Biosciences is a pharmaceutical company.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence
CME Headlines
  • New Product Summary: Initial Listing of Fifty-Five (55) Single Stock Futures Contracts — Effective July 27, 2026
    27 Jul · 4:32 PM
  • New Product Summary: Initial Listing of Twenty-Two (22) Micro Single Stock Futures Contracts - Effective July 27, 2026
    27 Jul · 4:11 PM
  • Initial Listing of Additional Event Contract Swaps on Pro Golf Tournaments
    9 Jul · 9:41 AM

How It Developed

2 Jun · 10:22 PM
Restates earlier reporting that Neurocrine Biosciences CSO Jude Onyia sold $1.76 million in stock.
Investing.com via PiQSuite
2 Jun · 10:11 PM
Neurocrine Biosciences' Chief Regulatory Officer sold $354,321 in stock.
Investing.com via PiQSuite

Sources

T1
Neurocrine Biosciences chief regulatory officer sells $354,321 in stockm.piqsuite.com
T1
Neurocrine Biosciences CSO Jude Onyia sells $1.76m in stockm.piqsuite.com

Related Stories

SpaceX Analyst Maintains Neutral Stance Amid Wall Street Buy Frenzy
8 Jul · 10:00 AM
Michael Burry Buys Flutter, DraftKings Shares on Prediction Market Threat
8 Jul · 9:51 PM
Zhipu AI Shares Rise After Lockup Expiry Amid Investor Support
8 Jul · 8:25 PM
SK Hynix $28B ADR bookbuild closes Wednesday amid strong demand
8 Jul · 7:57 AM
JPMorgan Hires Michael Flynn to Lead New Small-Cap Banking Business
8 Jul · 3:03 PM